BridgeBio Pharma, Inc.
A biopharmaceutical headquarters on Kipling Street in downtown Palo Alto, developing medicines for patients.
Acerca de
BridgeBio Pharma, Inc. is a Nasdaq-listed biopharmaceutical company, ticker BBIO, whose annual report and registration statement name 421 Kipling Street in downtown Palo Alto as its principal executive offices, a short walk from University Avenue. The chamber's record lists Eric Aguiar, a board member, as the contact. This is a corporate headquarters rather than a clinic or a shop, so there is nothing to buy or book at the front door.
What the company says it does
BridgeBio's own website sums up its purpose in one line: to bring meaningful medicines to patients quickly and safely. In practice, a company of this kind usually runs research programmes, sponsors clinical trials at hospitals and study centres, and works with regulators on the route to approval. Patients rarely deal with the Palo Alto office directly; enrolment in a trial happens through the study sites and the doctors running each one.
The filings that confirm the address and the 650-391-9740 number date from 2019 to 2021. They are the firmest public record of the headquarters, but a company that has grown since going public may have added or moved space, so check the current address before sending anything by courier.
Reasons to get in touch
People who contact a drug developer's head office tend to fall into a handful of groups: patients and families asking about a study, physicians with medical questions, job seekers, suppliers and investors. Each has its own channel. Trial questions go best through the study's public registry entry or your own doctor, employment and vendor enquiries through the company's website, and shareholder matters through its investor pages and SEC filings. For chamber business, networking or a local partnership idea, the chamber can pass a note to the listed contact.
Palo Alto and the Peninsula
Downtown Palo Alto sits at the northern tip of Santa Clara County, beside Stanford and across San Francisquito Creek from Menlo Park. The company's work reaches patients far beyond the Bay Area, but the chamber places it among Palo Alto, Stanford, Mountain View, Los Altos, Los Altos Hills, Sunnyvale and Santa Clara, a stretch of the county with a long history of research companies.
The main line given in the company's SEC filings is 650-391-9740. Its website, bridgebio.com, and its LinkedIn, Facebook and Instagram pages carry current news and contact routes.
Servicios
Típico de este tipo de negocioThe laboratory and development work a biopharmaceutical company usually carries out to move a drug candidate from early research toward testing in people.
Funding and organising studies run at hospitals and research centres; patients take part through the study sites and their doctors, not through the headquarters office.
Preparing the data and applications that regulators such as the U.S. Food and Drug Administration review before a new medicine can be approved and prescribed.
Channels a drug developer usually keeps for physicians and families with questions about its programmes; the company's website is the place to find the current route.
Public reporting to shareholders of a Nasdaq-listed company, including the annual and quarterly filings available through the SEC's EDGAR database.
Detalles
Ubicación y zona de servicio
Palo Alto, CA 94301-1530
Preguntas frecuentes
Típico de este tipo de negocioCan I visit BridgeBio's Palo Alto office?
The Kipling Street address is a corporate headquarters, not a clinic or retail location, so there is no public walk-in service. Use the phone number or the contact routes on the company's website instead.
How can I find out about a clinical trial?
Search ClinicalTrials.gov by the sponsor's name or the condition you are interested in, and talk to your own doctor. Each listed study names its sites and contacts, which handle screening and enrolment.
Is BridgeBio a public company?
Yes. It trades on Nasdaq under the ticker BBIO, and its annual reports, quarterly reports and other filings are free to read on the SEC's EDGAR website.
Is the headquarters still at 421 Kipling Street?
SEC filings from 2019 to 2021 give that address and the 650-391-9740 number. Check the company's latest filing or website for the current address before sending mail or deliveries.
Antes de contratar
- Confirm the current headquarters address in the latest SEC filing before sending mail or deliveries
- Route clinical trial questions through the study's registry entry or your own doctor
- Use the contact routes on bridgebio.com for jobs, suppliers and media
- Rely on SEC filings and the investor pages for shareholder information
- Expect no public walk-in reception at a corporate office
Resumen en español
BridgeBio Pharma, Inc. es una empresa biofarmacéutica que cotiza en Nasdaq con el símbolo BBIO. Sus informes ante la SEC indican que su sede principal está en 421 Kipling Street, en el centro de Palo Alto, con el teléfono 650-391-9740. No es una clínica ni una tienda: los pacientes interesados en un estudio clínico deben consultar ClinicalTrials.gov o a su médico. Como esos documentos son de 2019 a 2021, conviene confirmar la dirección actual antes de enviar correspondencia. El sitio bridgebio.com y sus redes sociales publican noticias y formas de contacto.
Los datos marcados como verificados se comprobaron el 29 de septiembre de 2026 con sec.gov y bridgebio.com. Los demás datos vienen de registros comerciales públicos o describen lo típico de este tipo de negocio, según se indica. El negocio aún no los ha confirmado.
¿Es el dueño? Confirme o corrija esta página →